{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":2,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":2,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"a505afb266a9","filters":{"venue":"Mebio oncology"}},"results":[{"id":"W618788809","doi":"","title":"What's going on 放射線 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. N Engl J Med. 2005; 352: 987-96. PMID: 15758009.--神経膠腫に対する治療として、放射線治療とテモゾロマイドの併用が世界的な標準的治療となりうることを示唆する論文","year":2006,"lang":"ja","type":"article","venue":"Mebio oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":772,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Temozolomide; Glioblastoma; Radiation therapy; Concomitant; Medicine; Nuclear medicine; Internal medicine; Cancer research","authors":[{"name":"則雄 荒木","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09719568561048682,"gpt":0.4371076186917973,"spread":0.3399119330813105,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008212435,0.0008441379,0.003276147,0.0005391855,0.000450821,0.0001339294,0.0002347317,0.0003888884,0.0002928946],"category_scores_gemma":[0.0007065902,0.0006773027,0.0003193662,0.0002659672,0.001016919,0.0003081049,0.00008183367,0.0003930864,0.000001194042],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00450471,"about_ca_system_score_gemma":0.003057898,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.04336387,"about_ca_topic_score_gemma":0.4355116,"domain_scores_codex":[0.9911864,0.002610092,0.002715674,0.001441695,0.0009314567,0.001114688],"domain_scores_gemma":[0.9880318,0.008817154,0.001561901,0.0004735315,0.0005743623,0.0005412655],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.07068101,0.01840604,0.1041302,0.001525768,0.01793565,0.0008705177,0.01074206,0.001268628,0.08498822,0.005257022,0.3471341,0.3370609],"study_design_scores_gemma":[0.1069629,0.02869286,0.04337848,0.001088661,0.001395175,0.00008499409,0.001945647,0.003314461,0.01229285,0.0002753081,0.7996698,0.0008988355],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8799358,0.06826539,0.0001171991,0.04048451,0.002408925,0.007146586,0.001477818,0.00002860192,0.000135178],"genre_scores_gemma":[0.9263319,0.06177983,0.001659579,0.004979942,0.00195731,0.001803984,0.0004524639,0.0002481554,0.0007867857],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4525357,"threshold_uncertainty_score":0.9995678,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W626102628","doi":"","title":"What's going on 放射線 Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, Knowling MA, Coppin CM, Weir L, Gelmon K, Le N, Durand R, Coldman AJ, Manji M. J Natl Cancer Inst. 2005; 97: 116-26. PMID: 15657341.--閉経前でリンパ節転移を有する高リスク乳癌症例において、術後化学療法に加え術後照射を行うことで生存率が改善することを無作為化比較試験で示した論文","year":2005,"lang":"ja","type":"article","venue":"Mebio oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Randomized controlled trial; Breast cancer; Cancer; Chemotherapy; Oncology; Adjuvant chemotherapy; Adjuvant radiotherapy; Internal medicine","authors":[{"name":"慶一郎 小岩井","is_ca":false},{"name":"直人 鹿間","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006359217929318061,"gpt":0.2382254718179619,"spread":0.2318662538886438,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001512558,0.001173036,0.002877557,0.0002288128,0.001027604,0.000500851,0.0008584562,0.001165975,0.0002532855],"category_scores_gemma":[0.0001834218,0.001153743,0.0006609899,0.0007402549,0.001199687,0.0001740081,0.0002560295,0.001008849,0.00001884596],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002182717,"about_ca_system_score_gemma":0.001639987,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.07445084,"about_ca_topic_score_gemma":0.2804337,"domain_scores_codex":[0.9911423,0.002008633,0.002276127,0.002084094,0.0009645552,0.001524342],"domain_scores_gemma":[0.994484,0.0004824566,0.002874376,0.001127186,0.0007239752,0.0003080079],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6145114,0.005591935,0.09613167,0.0001773582,0.003173832,0.00002527995,0.001586017,0.002784021,0.001046083,0.000006265667,0.01643628,0.2585298],"study_design_scores_gemma":[0.7003316,0.00256701,0.2489209,0.002261957,0.0005708939,0.00002489756,0.0004577,0.0002670741,0.002571683,0.00002413649,0.04068477,0.001317384],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9606836,0.02173625,0.00001358812,0.006610924,0.002646609,0.006529354,0.001492465,0.00006493099,0.0002222099],"genre_scores_gemma":[0.8947306,0.09831692,0.0002119324,0.001197054,0.001852032,0.001300444,0.0005273712,0.000263129,0.001600583],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2572124,"threshold_uncertainty_score":0.9990913,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}